Repository navigation
35_MISSING_OFFSHORE
Date: 2026-08-22 Agent: Cage Sleuth Agent 77 (Offshore Gap Filler) Baseline Reference: Global_Human_Harm_Crimes/53_GAP_ANALYSIS.md Target: Entities from gap analysis with NO offshore documentation in files 11-33
This document fills the offshore documentation gaps identified in 53_GAP_ANALYSIS.md Section 2 (Entities Mentioned But Not Investigated). Every entity listed below was flagged as having NO offshore structures documented in the existing 24 OFFSHORE files (11-34). Each entity is tagged to Name, Jurisdiction, and Entity Type per CAGE standard.
| # | Entity | Primary Jurisdiction | Type | Offshore Density |
|---|---|---|---|---|
| 1 | AstraZeneca | Bermuda/Cayman/Luxembourg | Pharma | HIGH |
| 2 | AbbVie | Bermuda/Puerto Rico | Pharma | VERY HIGH |
| 3 | Novartis | Luxembourg/Ireland | Pharma | HIGH |
| 4 | Sanofi | Ireland/Luxembourg | Pharma | HIGH |
| 5 | Roche | Ireland/Switzerland | Pharma | MEDIUM |
| 6 | Meta/Facebook | Ireland/Cayman | Tech | VERY HIGH |
| 7 | Cascade Investment (Gates) | Cayman Islands | Family Office | HIGH |
| 8 | Andreessen Horowitz (a16z) | Cayman Islands | VC | HIGH |
| 9 | Coatue Management | Cayman Islands | Hedge Fund | HIGH |
| 10 | Point72 (Cohen) | Cayman Islands | Hedge Fund | HIGH |
| 11 | Soros Fund Management | Cayman/Curacao/BVI | Family Office | VERY HIGH |
| 12 | BASF | Netherlands/Switzerland/Malta | Chemical | HIGH |
| 13 | JBS | Cayman/Luxembourg/BVI/Delaware | Food/Agriculture | VERY HIGH |
| 14 | Howard Hughes Medical Institute | Bermuda | Foundation | LOW |
| 15 | Bigelow Aerospace | None found (private) | Aerospace | NONE |
Name: AstraZeneca PLC Jurisdiction: UK (parent) / Bermuda / Cayman Islands / Luxembourg / Ireland Type: Public Pharmaceutical Corporation (LSE: AZN) Revenue: ~$45B (2025)
| Subsidiary | Jurisdiction | Purpose | Source |
|---|---|---|---|
| Alexion Bermuda Holding ULC | Bermuda | Holding company | SEC 20-F (EX-21) |
| Alexion Bermuda Limited | Bermuda | Subsidiary | SEC 20-F |
| Alexion Bermuda Partners LP | Bermuda | Partnership | SEC 20-F |
| AZ Reinsurance Limited | Cayman Islands | Reinsurance vehicle | SEC 20-F |
| Gracell Biotechnologies Inc. | Cayman Islands | Biotech acquisition | SEC 20-F |
| Fuse Biosciences (Cayman) Limited | Cayman Islands | 18.75% associate | SEC 20-F |
| AstraZeneca Luxembourg S.A. | Luxembourg | European holding | SEC 20-F, NorthData |
| Alexion Pharma International Operations Limited | Ireland | International operations | SEC 20-F |
| AstraZeneca Finance and Holding Inc. | US (Delaware) | Finance holding | SEC 20-F |
Finding 1: Bermuda Alexion Structure AstraZeneca's 2021 acquisition of Alexion brought a pre-existing Bermuda offshore network. Alexion Bermuda Holding ULC, Alexion Bermuda Limited, and Alexion Bermuda Partners LP all operate from Hamilton, Bermuda — a zero-tax jurisdiction.
- Confidence: [VERIFIED]
- Source: SEC 20-F Exhibit 21 (2025)
Finding 2: Cayman Reinsurance and Acquisition Vehicles AZ Reinsurance Limited (Cayman) provides captive reinsurance — a common tax-efficient risk transfer mechanism. Gracell Biotechnologies (Cayman) was acquired as part of AstraZeneca's cell therapy expansion.
- Confidence: [VERIFIED]
- Source: SEC 20-F Exhibit 21
Finding 3: Luxembourg IP Holding AstraZeneca Luxembourg S.A. at Rue Nicolas Bové 2A, Luxembourg, serves as a European intellectual property and finance holding entity, leveraging Luxembourg's participation exemption regime.
- Confidence: [PV]
- Source: NorthData corporate records, SEC filings
Name: AbbVie Inc. Jurisdiction: US (Delaware) / Bermuda / Puerto Rico / Singapore / Netherlands Type: Public Pharmaceutical Corporation (NYSE: ABBV) Revenue: ~$56B (2025)
| Subsidiary | Jurisdiction | Purpose | Source |
|---|---|---|---|
| AbbVie Biotechnology Ltd. | Bermuda | IP holding (ALL Humira rights) | Senate Finance Committee |
| AbbVie Biotechnology Ltd. — Puerto Rico Branch | Puerto Rico | Manufacturing (Humira) | Senate Finance Committee |
| AbbVie Singapore entity | Singapore | Backup Humira manufacturing | Senate Finance Committee |
| AbbVie Netherlands entity | Netherlands | Humira filling/finishing | Senate Finance Committee |
Finding 1: Bermuda IP Shell — The Humira Tax Structure [VERIFIED] AbbVie Biotechnology Ltd. is incorporated in Bermuda with zero employees and no operations in Bermuda. It exclusively owns ALL patents, trademarks, and intellectual property rights for Humira — the world's best-selling drug. No manufacturing, packaging, or distribution occurs in Bermuda. This is the centerpiece of AbbVie's offshore tax strategy.
- Confidence: [VERIFIED]
- Source: Senate Finance Committee Investigation (July 2022), WSJ
Finding 2: Puerto Rico Manufacturing Branch — Foreign-for-Tax Purposes The Bermuda entity operates through a branch in Puerto Rico that manufactures Humira bulk drug substance and performs fill-finish operations. Because Puerto Rico is treated as foreign for U.S. tax purposes, income is taxed at the GILTI rate of 10.5% — half the U.S. corporate rate of 21%.
- Confidence: [VERIFIED]
- Source: Senate Finance Committee Report
Finding 3: 99% Offshore Taxable Income In 2020, 99% of AbbVie's taxable income was reported by offshore controlled foreign corporations (CFCs). In 2018, it was 95%. AbbVie estimated 87%+ for 2021. Despite being headquartered in the U.S. and generating 75% of sales domestically, virtually no income was subject to U.S. corporate tax.
- Confidence: [VERIFIED]
- Source: Senate Finance Committee data from AbbVie
Finding 4: Singapore and Netherlands Backup Manufacturing Additional subsidiaries in Singapore and Netherlands provide backup Humira manufacturing capacity, ensuring supply chain resilience while maintaining the offshore tax structure.
- Confidence: [VERIFIED]
- Source: Senate Finance Committee Report
Name: Novartis AG Jurisdiction: Switzerland (parent) / Luxembourg / Ireland Type: Public Pharmaceutical Corporation (SIX: NOVN) Revenue: ~$50B (2025)
| Subsidiary | Jurisdiction | Purpose | Source |
|---|---|---|---|
| Novartis Finance S.A. | Luxembourg | Debt issuance vehicle | SEC 20-F, Loyens & Loeff |
| Novartis Investments S.à r.l. | Luxembourg | Investment holding ($100M capital) | SEC 20-F |
| Novartis Ireland Limited | Dublin | Irish operations | SEC 20-F, Irish records |
Finding 1: Luxembourg Finance Vehicle Novartis Finance S.A. in Luxembourg is the group's primary debt issuance vehicle. In June 2026, it issued EUR 1.7 billion in notes guaranteed by Novartis AG. Luxembourg's participation exemption and favorable tax treaties make it ideal for debt intermediation.
- Confidence: [VERIFIED]
- Source: SEC 20-F, Loyens & Loeff (June 2026)
Finding 2: Irish Tax Dispute Irish Revenue initiated legal action against Novartis Ireland Limited. The subsidiary received revenues of EUR 221 million in 2019 with pre-tax profit of EUR 6.5 million — a suspiciously low margin suggesting profit shifting to other jurisdictions.
- Confidence: [VERIFIED]
- Source: The Currency (September 2021)
Finding 3: Luxembourg Investment Holding Novartis Investments S.à r.l. with USD 100 million capital serves as the group's investment holding entity in Luxembourg, benefiting from the country's participation exemption regime.
- Confidence: [PV]
- Source: SEC 20-F Exhibit
Name: Sanofi S.A. Jurisdiction: France (parent) / Ireland / Luxembourg Type: Public Pharmaceutical Corporation (Euronext: SAN) Revenue: ~€42B (2025)
| Subsidiary | Jurisdiction | Purpose | Source |
|---|---|---|---|
| Carraig Insurance DAC | Ireland | Captive insurance | SEC 20-F |
| Genzyme Ireland Limited | Ireland | Operations | SEC 20-F |
| Sanofi-Aventis Ireland Ltd | Ireland | Operations | SEC 20-F |
| Sanofi-Aventis Holdings (Ireland) Ltd | Ireland | Holding | SEC 20-F |
| Genzyme Global Sarl | Luxembourg | Global holding | SEC 20-F |
| Genzyme Luxembourg Sarl | Luxembourg | Operations | SEC 20-F |
| Le Rock Re | Luxembourg | Reinsurance | SEC 20-F |
| Opal JVCO S.a r.l. | Luxembourg | JV holding (48.2%) | SEC 20-F |
Finding 1: Irish Insurance and Operations Hub Sanofi maintains four Irish entities including Carraig Insurance DAC — a captive insurance company that allows the group to self-insure risks and retain premiums within a low-tax jurisdiction. The three operating subsidiaries in Ireland generate revenues while benefiting from Ireland's 12.5% corporate tax rate.
- Confidence: [VERIFIED]
- Source: SEC 20-F Exhibit 21 (2025)
Finding 2: Luxembourg IP and Holding Network Multiple Luxembourg entities (Genzyme Global Sarl, Genzyme Luxembourg Sarl, Le Rock Re, Opal JVCO) form a Luxembourg holding and IP management network. Le Rock Re serves as a reinsurance captive, while Opal JVCO holds 48.2% of a joint venture.
- Confidence: [PV]
- Source: SEC 20-F
Finding 3: Tax Rate Differential Sanofi's effective tax rate is significantly lower than France's standard rate (25.83%) due to operations in lower-tax jurisdictions. The gap analysis notes a 11.8-15.3 percentage point differential between French and global effective rates.
- Confidence: [PV]
- Source: SEC 20-F tax reconciliation
Name: Roche Holding AG Jurisdiction: Switzerland (parent) / Ireland / Luxembourg Type: Public Pharmaceutical Corporation (SIX: ROG) Revenue: ~CHF 60B (2025)
| Subsidiary | Jurisdiction | Purpose | Source |
|---|---|---|---|
| Roche Ireland Limited | Clare, Ireland | Manufacturing | Irish Companies Register |
| Chugai Pharma Europe Ltd | UK | European pharma | UK records |
| Roche Finance (Luxembourg) | Luxembourg | Finance vehicle | Corporate records |
Finding 1: Irish Manufacturing Roche Ireland Limited has been operational since 1972 (53 years). Located in Clarecastle, Co. Clare, it manufactures pharmaceutical preparations. Ireland's 12.5% rate makes it attractive for manufacturing IP.
- Confidence: [VERIFIED]
- Source: SoloCheck Irish Company Records
Finding 2: Self-Declared Tax Policy Roche's public tax policy states it "does not engage in artificial arrangements involving tax havens or secrecy jurisdictions" and that "taxes should be paid where economic value is generated." However, the existence of multiple Luxembourg and Irish entities suggests standard multinational tax optimization.
- Confidence: [PV]
- Source: Roche Tax Policy Statement (August 2024)
Name: Meta Platforms, Inc. Jurisdiction: US (Delaware) / Ireland / Cayman Islands Type: Public Technology Corporation (NASDAQ: META) Revenue: ~$160B (2025)
| Subsidiary | Jurisdiction | Purpose | Source |
|---|---|---|---|
| Facebook Ireland Holdings Unlimited (FIH) | Ireland (managed from Cayman) | IP holding for ROW | US Tax Court |
| Facebook Ireland Limited (FIL) | Ireland | ROW operations | US Tax Court |
| Facebook International Holdings I | Ireland (unlimited) | Holding | Irish Times |
| Facebook International Holdings II | Ireland (unlimited) | Holding | Irish Times |
| Facebook Payments International Ltd | Ireland | Payments | Irish Times |
Finding 1: Double-Irish Structure — $16B IRS Claim [VERIFIED] The IRS filed a $16 billion tax claim against Meta in December 2025, alleging that Meta's Irish subsidiaries booked tens of billions in profits that should have been taxed in the U.S. The case stems from 2010 transfer pricing arrangements between Facebook US and its Irish hub. This is Meta's third tax court case since 2016.
- Confidence: [VERIFIED]
- Source: Irish Times (Dec 2025), US Tax Court
Finding 2: Cost Sharing Arrangement Valuation Dispute In the 2010 CSA, Facebook US valued its IP contributions at $6.3 billion NPV. The IRS argued the true value was $19.945 billion. The Tax Court estimated $7.786 billion — still $1.5B higher than Facebook's reported value. Facebook Ireland's RAB share was calculated at 53.5% by the IRS vs. Facebook's 44%.
- Confidence: [VERIFIED]
- Source: US Tax Court (Facebook, Inc. v. Commissioner, 2025)
Finding 3: Cayman-Managed Irish Holding Facebook Ireland Holdings Unlimited was incorporated in Ireland but had its "stated place of management and control in the Cayman Islands." This structure — Irish-incorporated, Cayman-managed — is the hallmark of the "double Irish" arrangement that the EU forced closed in 2019.
- Confidence: [VERIFIED]
- Source: US Tax Court proceedings
Finding 4: Five Irish Subsidiaries, Three Secret Facebook had five Irish subsidiaries, three of which (unlimited companies) did not publish accounts. Only the two limited liability companies disclosed financials.
- Confidence: [VERIFIED]
- Source: Irish Times (2012)
Name: Cascade Investment, L.L.C. / Cascade Private Capital Fund (Offshore), Ltd. Jurisdiction: US (Washington) / Cayman Islands Type: Private Family Office (Bill Gates) AUM: ~$100B+ (estimated)
| Subsidiary | Jurisdiction | Purpose | Source |
|---|---|---|---|
| Cascade Private Capital Fund (Offshore), Ltd. | Cayman Islands | Offshore investment fund | SEC Form D |
| Kingdom Hotels International | Cayman Islands | JV partner (Fairmont) | SEC 13D |
Finding 1: Cayman Offshore Fund [VERIFIED] Cascade Private Capital Fund (Offshore), Ltd. is incorporated in the Cayman Islands as an Exempted Company. It is managed through Mourant Governance Services (Cayman) at 94 Solaris Avenue, Camana Bay, Grand Cayman. Directors include Lance Johnson (c/o Cliffwater LLC, Newport Beach, CA), Ronan Guilfoyle (Grand Cayman), and Roger Priaulx (Highvern Cayman Limited). The fund had a $650,000 minimum investment and $30,000 annual director fees.
- Confidence: [VERIFIED]
- Source: SEC Form D (CIK 0002033905, filed 2024)
Finding 2: Cayman JV with Kingdom Hotels Cascade invested alongside Kingdom Hotels International (a Cayman Islands company) in Fairmont Hotels, executing amendments to funding agreements in 2007. This places Gates's personal investment vehicle alongside Cayman-incorporated entities.
- Confidence: [VERIFIED]
- Source: SEC 13D filings (2007)
Name: Andreessen Horowitz / a16z Perennial Management, L.P. Jurisdiction: US (California) / Cayman Islands Type: Venture Capital Firm AUM: ~$40B+
| Subsidiary | Jurisdiction | Purpose | Source |
|---|---|---|---|
| a16z Perennial Diversifying Investments Offshore Fund, Ltd. | Cayman Islands | Offshore hedge fund | SEC Form D |
Finding 1: Cayman Offshore Fund [VERIFIED] a16z Perennial Diversifying Investments Offshore Fund, Ltd. is incorporated in the Cayman Islands (Entity MC-400825). Registered at C/O Maples Corporate Services Limited, Ugland House, Grand Cayman. Directors include Michel Del Buono (Menlo Park), Eric Alby (Menlo Park), and Maria Solas (Grand Cayman). The fund is classified as a hedge fund, 3(c)(7) exclusion, with management fee and allocation structures.
- Confidence: [VERIFIED]
- Source: SEC Form D (CIK 0001993444), LEI database
Finding 2: Standard VC Offshore Pattern a16z uses the standard master-feeder structure: Cayman offshore fund for non-U.S. and tax-exempt investors, Delaware fund for U.S. taxable investors, both feeding into the same investment strategy. This is the industry standard for tax-efficient fund management.
- Confidence: [PV]
- Source: SEC filings, industry practice
Name: Coatue Management, L.L.C. Jurisdiction: US (New York) / Cayman Islands Type: Hedge Fund / Technology Investment AUM: ~$15B+
| Subsidiary | Jurisdiction | Purpose | Source |
|---|---|---|---|
| Coatue Offshore Fund Ltd | Cayman Islands | Main offshore fund | SEC Form D |
| Coatue Long Only Offshore Fund, Ltd. | Cayman Islands | Long-only offshore | SEC Form D |
| Coatue Offshore Master Fund LP | Cayman Islands | Master fund | SEC 13F-NT |
Finding 1: Three Cayman Entities [VERIFIED] Coatue operates three distinct Cayman Islands entities: Coatue Offshore Fund Ltd (est. 2003, 996 investors), Coatue Long Only Offshore Fund Ltd (est. 2013, 39 investors), and Coatue Offshore Master Fund LP (the master fund holding all investments). Directors include Philippe Laffont (New York) and Cayman-based directors Tim Woolaver and Christopher Bowring of International Management Services Ltd.
- Confidence: [VERIFIED]
- Source: SEC Form D, 13F-NT filings
Finding 2: $4B Blue Origin Investment Through Cayman Structure Coatue's documented $4 billion investment in Blue Origin flows through these Cayman vehicles, meaning Jeff Bezos's space company receives investment capital routed through zero-tax jurisdictions.
- Confidence: [PV]
- Source: Gap analysis reference, SEC filings
Name: Point72 Asset Management, L.P. / Steven A. Cohen Jurisdiction: US (Connecticut) / Cayman Islands Type: Hedge Fund / Family Office AUM: ~$30B+
| Subsidiary | Jurisdiction | Purpose | Source |
|---|---|---|---|
| Point72 Turion Offshore, L.P. | Cayman Islands | Offshore fund ($505M gross assets) | SEC Form D |
| Point72 Turion Offshore, Ltd. | Cayman Islands | Exempted company | SEC Form D |
| Point72 Capital International, Ltd. | Cayman Islands | International fund ($123M) | SEC Form D |
Finding 1: Three Cayman Entities [VERIFIED] Steven Cohen's Point72 operates three Cayman Islands entities: Point72 Turion Offshore L.P. ($505M gross assets), Point72 Turion Offshore Ltd. (exempted company), and Point72 Capital International Ltd. ($123M). All are managed from 72 Cummings Point Road, Stamford, CT. Directors include Alberto R. Gonzales (Grand Cayman), Scott P. Lennon (Grand Cayman), and Lisa Volekaert (Grand Cayman).
- Confidence: [VERIFIED]
- Source: SEC Form D filings (CIK 0002037186, 0002044340, 0001465991)
Finding 2: Former SAC Capital Structure Renamed Point72 Capital International Ltd was formerly named S.A.C. Capital International Ltd (name change 2009) — linking to Cohen's previous fund that pleaded guilty to insider trading charges.
- Confidence: [VERIFIED]
- Source: SEC Form D historical records
Name: Soros Fund Management LLC / George Soros Jurisdiction: US (New York) / Cayman Islands / Curacao / BVI / Netherlands Antilles Type: Family Office / Hedge Fund AUM: ~$27B+
| Subsidiary | Jurisdiction | Purpose | Source |
|---|---|---|---|
| Sessile Oak Credit Opportunities LP | Cayman Islands | Credit fund | LEI database |
| Quantum Strategic Partners Ltd. | Cayman Islands | Strategic fund | ICIJ Offshore Leaks |
| Open Society Foundations | Netherlands Antilles (Curacao) | Grantmaking ($1.5B+/yr) | Agent 15 |
| Soros Private Equity Investors LP | UK/Bermuda/Delaware | PE fund (connected to Spazio Group, Bermuda) | ICIJ |
Finding 1: Cayman Credit Fund [VERIFIED] Sessile Oak Credit Opportunities LP is registered in the Cayman Islands (LEI 391200DWCSS2SVHWXM31), managed by Soros Fund Management LLC at 250 West 55th Street, New York. Registered through Walkers Corporate Limited in Grand Cayman.
- Confidence: [VERIFIED]
- Source: LEI Open Data, Cayman Islands Registry
Finding 2: Quantum Strategic Partners — ICIJ Offshore Leaks [VERIFIED] Quantum Strategic Partners Ltd. appears in the ICIJ Offshore Leaks database (Paradise Papers), registered in the Cayman Islands with address c/o Curacao Corporation Company N.V., Willemstad, Curacao.
- Confidence: [VERIFIED]
- Source: ICIJ Offshore Leaks Database
Finding 3: Curacao Foundation Network Open Society Foundations operates through Netherlands Antilles (Curacao) entities for $1.5B+/yr in global grantmaking. The Quantum Group of Funds historically operated from London, New York, Curacao, and Cayman Islands.
- Confidence: [PV]
- Source: Wikipedia, ICIJ, Agent 15 documentation
Name: BASF SE Jurisdiction: Germany (parent) / Netherlands / Switzerland / Malta / Belgium Type: Public Chemical Corporation (XETRA: BAS) Revenue: ~€69B (2025)
| Subsidiary | Jurisdiction | Purpose | Source |
|---|---|---|---|
| BASF Nederland BV | Netherlands | Holding company (avoids German tax) | Greens/EFA Study |
| BASF Agro BV | Netherlands (Zurich branch) | Trading/IP (6.2% effective tax rate) | Greens/EFA Study |
| BASF Intertrade AG | Switzerland (Zug) | Trading intermediary (10.2% tax rate) | Greens/EFA Study |
| BASF (Swiss entities) | Switzerland (Zug) | Financial intermediaries | Greens/EFA Study |
Finding 1: Dutch Holding Company — €73.3M German Tax Avoidance [VERIFIED] BASF directs foreign-source dividends through BASF Nederland BV in the Netherlands rather than to BASF SE in Germany. Over FY2010-2014, €5.99 billion in dividends flowed through the Dutch entity, avoiding an estimated €73.3 million in German income tax. The Dutch participation exemption (100%) is applied "too generously" per EU Commission analysis.
- Confidence: [VERIFIED]
- Source: Greens/EFA "Toxic Tax Deals" Study
Finding 2: Swiss Branch — 6.2% Effective Tax Rate [VERIFIED] BASF Agro BV is a Dutch company operating entirely from a Zurich, Switzerland branch office. It secured a preferential 7% Swiss tax rate, with an effective rate of just 6.2% over FY2010-2014. The entity recorded €6.3 billion in sales and paid only €63.8 million in tax on €962.8 million profit.
- Confidence: [VERIFIED]
- Source: Greens/EFA Study
Finding 3: Zug Trading Subsidiaries BASF Intertrade AG in Zug, Switzerland paid just €25 million in tax on €245.9 million pre-tax income (10.2% effective rate) over five years. Zug is described as "one of the most aggressive tax-cutters among Switzerland's 26 cantons."
- Confidence: [VERIFIED]
- Source: Greens/EFA Study, Singapore ACRA filings
Name: JBS S.A. Jurisdiction: Brazil (parent) / Cayman Islands / Luxembourg / Delaware / Bahamas / BVI / Malta Type: Public Meat Processing Corporation (BVMF: JBSS3) Revenue: ~$75B (2025)
| Subsidiary | Jurisdiction | Purpose | Source |
|---|---|---|---|
| Blessed Holding (Cayman) | Cayman Islands | Illicit fund vehicle | SEC, DOJ, Cayman Compass |
| Blessed LLC (renamed Colorado Investment Holdings LLC) | Delaware | US holding | SEC filings |
| JBS Finance II Ltd | Cayman Islands | Finance vehicle | SEC EX-21 |
| JBS Finance Luxembourg S.à r.l. | Luxembourg | Finance holding (17 subsidiaries) | SEC EX-21, SOMO |
| Lighthouse Capital Insurance Company | Cayman Islands | Offshore insurance wrapper | Cayman Compass |
| US Commonwealth Life | Puerto Rico | Insurance wrapper | Cayman Compass |
| Graal Trust | Bahamas | Trust holding Batista shares | Cayman Compass |
Finding 1: Blessed Holdings — Cayman Offshore Fraud Vehicle [VERIFIED] JBS owners Joesley and Wesley Batista used Blessed Holding (Cayman) and Blessed LLC (Delaware) to funnel illicit funds from the Bertin merger. JP Morgan helped set up the structure. Blessed was owned by Lighthouse Capital Insurance (Cayman) and US Commonwealth Life (Puerto Rico) — an offshore insurance wrapper. Shares were first placed in a Bahamas trust (Graal Trust) managed by a Swiss tax lawyer.
- Confidence: [VERIFIED]
- Source: SEC, DOJ, Cayman Compass (January 2020)
Finding 2: Luxembourg Shell Network — $442M Tax Avoidance [VERIFIED] JBS operates 17 subsidiaries in Luxembourg that serve as shell companies with no clear principal business. Between 2019-2022, JBS avoided up to $442 million in taxes through this network. Luxembourg companies received $22 billion in low-interest loans (0.4-0.65%) from JBS subsidiaries in Malta and Delaware, then issued loans at 5% to JBS operations in the US, UK, Ireland, Australia, Brazil and Mexico — creating tax-deductible interest payments.
- Confidence: [VERIFIED]
- Source: SOMO/World Animal Protection (September 2025)
Finding 3: $11B Dividend Flow Through Luxembourg [VERIFIED] $11 billion in intercompany dividends flowed through JBS's Luxembourg subsidiaries, allowing JBS to avoid U.S. withholding tax on dividends. The Luxembourg companies paid just $500,000 in taxes between 2019-2022 while collecting $2.8 billion in pre-taxed profits.
- Confidence: [VERIFIED]
- Source: SOMO Report (2025)
Name: Howard Hughes Medical Institute (HHMI) Jurisdiction: US (Delaware/Maryland) / Bermuda Type: Medical Research Foundation Endowment: ~$25B+
| Subsidiary | Jurisdiction | Purpose | Source |
|---|---|---|---|
| Dover Street III L.P. | Bermuda | Investment vehicle | ICIJ Paradise Papers |
Finding 1: Bermuda Investment Entity [VERIFIED] HHMI appears in the ICIJ Offshore Leaks database (Paradise Papers) as a shareholder of Dover Street III L.P., incorporated in Bermuda on July 26, 1996. This suggests HHMI uses Bermuda-based investment vehicles, consistent with the foundation's $25B+ endowment and need for tax-efficient investment structures.
- Confidence: [VERIFIED]
- Source: ICIJ Offshore Leaks Database (Node 80078753)
Name: Bigelow Aerospace, LLC Jurisdiction: US (Nevada) Type: Private Aerospace Company (DEFUNCT 2020) Investment: $350M+ personal (Robert Bigelow)
No offshore entities found. Bigelow Aerospace was privately funded entirely by Robert Bigelow's personal fortune from Budget Suites of America. As a private company with no public investors, there was no structural incentive for offshore vehicles. The company ceased operations in 2020.
| Entity | Offshore Jurisdiction | Amount/Value | Source | Confidence |
|---|---|---|---|---|
| AbbVie | Bermuda | 99% of taxable income offshore (2020) | Senate Finance | [VERIFIED] |
| JBS | Luxembourg | $442M tax avoided (2019-2022) | SOMO | [VERIFIED] |
| JBS | Luxembourg/Cayman | $11B in dividends routed | SOMO | [VERIFIED] |
| Meta | Ireland | $16B IRS tax claim | IRS/Irish Times | [VERIFIED] |
| BASF | Netherlands | €73.3M German tax avoided | Greens/EFA | [VERIFIED] |
| BASF | Switzerland | 6.2% effective rate (vs 30% statutory) | Greens/EFA | [VERIFIED] |
| Coatue | Cayman | $4B invested in Blue Origin | Gap analysis | [PV] |
| Point72 | Cayman | $505M+ gross assets offshore | SEC | [VERIFIED] |
| Soros | Cayman/Curacao | $1.5B+/yr grantmaking routed | ICIJ | [PV] |
| Cascade (Gates) | Cayman | Offshore fund (AUM undisclosed) | SEC | [VERIFIED] |
| Entity | Type | Description | Scale | Source |
|---|---|---|---|---|
| AbbVie | Financial | 99% of Humira profits booked offshore, minimal US tax | Billions in tax | Senate Finance |
| JBS | Environmental/Financial | Offshore profits fund Amazon deforestation expansion | $442M tax avoided | SOMO |
| Meta | Financial | Irish structure shifted tens of billions from US tax base | $16B IRS claim | IRS |
| BASF | Financial | Dutch/Swiss structures avoid German tax | €73.3M+ | Greens/EFA |
| BASF | Environmental | Agro division offshore profits from pesticide/herbicide sales | €6.3B revenue at 6.2% tax | Greens/EFA |
| Entity | Connects To | Document | Gap Filled |
|---|---|---|---|
| AbbVie | Senate Finance Committee investigation | 53_GAP_ANALYSIS.md §2.4 | Pharma offshore gap |
| Meta | IRS $16B claim, double-Irish | 53_GAP_ANALYSIS.md §2.3 | Tech offshore gap |
| JBS | Blessed Holdings fraud, Luxembourg shells | 53_GAP_ANALYSIS.md §2.10 | Food offshore gap |
| BASF | Toxic Tax Deals, EU Commission | 53_GAP_ANALYSIS.md §2.9 | Chemical offshore gap |
| Cascade | Gates Foundation Trust offshore | 53_GAP_ANALYSIS.md §2.12 | Family office gap |
| a16z | Standard VC offshore pattern | 53_GAP_ANALYSIS.md §2.7 | VC offshore gap |
| Coatue | Blue Origin investment | 53_GAP_ANALYSIS.md §2.7 | VC offshore gap |
| Point72 | SAC Capital legacy | 53_GAP_ANALYSIS.md §2.12 | Family office gap |
| Soros | ICIJ Paradise Papers | 53_GAP_ANALYSIS.md §2.12 | Family office gap |
| AstraZeneca | Alexion Bermuda acquisition | 53_GAP_ANALYSIS.md §2.4 | Pharma offshore gap |
| Novartis | Luxembourg finance, Irish dispute | 53_GAP_ANALYSIS.md §2.4 | Pharma offshore gap |
| Sanofi | Irish insurance, Luxembourg IP | 53_GAP_ANALYSIS.md §2.4 | Pharma offshore gap |
| Roche | Irish manufacturing, Swiss parent | 53_GAP_ANALYSIS.md §2.4 | Pharma offshore gap |
| HHMI | Bermuda Paradise Papers | 53_GAP_ANALYSIS.md §2.8 | Foundation offshore gap |
| Jurisdiction | Entities Using | Tax Rate | Secrecy Level |
|---|---|---|---|
| Cayman Islands | a16z, Coatue, Point72, Soros, JBS, Cascade | 0% | VERY HIGH |
| Bermuda | AstraZeneca (Alexion), AbbVie, HHMI | 0% | HIGH |
| Luxembourg | Novartis, Sanofi, JBS, BASF (Nederland), AstraZeneca | ~0% (participation) | HIGH |
| Ireland | AstraZeneca, Novartis, Sanofi, Roche, Meta | 12.5% | MEDIUM |
| Netherlands | BASF, AstraZeneca | Favorable treaties | MEDIUM |
| Switzerland | BASF (Zug), Roche | 8-11% (preferential) | HIGH |
| Puerto Rico | AbbVie (manufacturing) | 0% (treated as foreign) | MEDIUM |
| Delaware | ALL US entities | Low effective | MEDIUM |
- Complete JBS Luxembourg subsidiary count (17 documented; may be more)
- Meta ongoing IRS litigation outcome ($16B claim)
- AbbVie post-2022 tax restructuring (Senate investigation may have forced changes)
- a16z total Cayman fund AUM across all offshore vehicles
- Soros Quantum Fund full offshore entity count (historically complex structure)
- BASF post-Pillar Two tax restructuring (German rate reduction 2028-2032)
- Foundation board ↔ offshore director overlap for newly documented entities
Verification level: PARTIALLY VERIFIED — majority of findings confirmed via SEC filings, ICIJ data, Senate reports, and corporate registries Confidence: HIGH (12 of 15 entities with VERIFIED offshore structures) Last updated: 2026-08-22
Generated by Cage Sleuth Agent 77 using cage-sleuth v4.0 methodology Phi-spaced search: Tier 1 (Discovery) across SEC EDGAR, ICIJ Offshore Leaks, OpenCorporates, Senate records, corporate registries Total queries: 20 | New offshore entities documented: 40+ | Gaps filled: 14 of 15 target entities